BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33602251)

  • 1. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity.
    Lan T; Wei Z; He Y; Wan S; Liu L; Cheng B; Li R; Chen H; Liu G; Meng Z
    Virol J; 2021 Feb; 18(1):37. PubMed ID: 33602251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
    Han Q; Zhang C; Zhang J; Tian Z
    Hepatology; 2011 Oct; 54(4):1179-89. PubMed ID: 21721030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of PLSCR1 on the Antiviral Activity of IFN against HBV in HepG2 Cells].
    Li Q; Zhang B; Zhang Q; Wang X; Huo Y; Yang J
    Bing Du Xue Bao; 2016 Nov; 32(6):747-51. PubMed ID: 30004207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the cytoplasmic DNA sensor DAI on replication of hepatitis B virus].
    Wang Q; Li S; Huang H; Liu S; Yang Y; Yang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):934-8. PubMed ID: 26739467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.
    Bian Z; Xiao A; Cao M; Liu M; Liu S; Jiao Y; Yan W; Qi Z; Zheng Z
    Virol J; 2012 Nov; 9():275. PubMed ID: 23158906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.
    Wei W; Wang SF; Yu B; Ni M
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):828-832. PubMed ID: 29270739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
    Han Q; Hou Z; Yin C; Zhang C; Zhang J
    Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of hepatitis B virus replication and expression by RNA interference in vitro].
    Zhu C; Fan XG; Li N; Ying RS; Tian XF
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2503-6. PubMed ID: 16321280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition.
    Han Q; Zhang C; Zhang J; Tian Z
    PLoS One; 2011; 6(12):e27931. PubMed ID: 22174754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
    Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
    He YW; Guo CX; Pan YF; Peng C; Weng ZH
    World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells.
    Zhang B; Liu Y; Wang X; Li J; Xu X; Guo L; Ho WZ
    Front Immunol; 2018; 9():2921. PubMed ID: 30619284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
    Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
    World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of hepatitis B virus replication by innate response of HepaRG cells.
    Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
    Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.